Indications |
Intramuscular Active immunisation against pertussis Adult: 11-64 yr: As combination product with diphtheria and tetanus toxoids: 0.5 ml as a single dose, preferably into the deltoid muscles. Ensure that 5 yr should have elapsed since the last dose of tetanus toxoid, diphtheria toxoid and/or pertussis containing vaccine. Child: As a combination product with diphtheria, tetanus, inactivated poliomyelitis and HIB conjugate vaccine: 3 doses of 0.5 ml each, given at 1 mth intervals. Booster dose may be given at 18 mth-6 yr of age prior to school entry (3 yr after primary course). |
Contraindications |
Hypersensitivity to active substances and/or neomycin, polymyxin or formaldehyde. |
Warnings / Precautions |
Continue immunisation with acellular pertussis vaccine even during episodes of fever, hypotonic-hyporesponsive episodes, persistent crying or screaming or severe local reactions have occurred after a preceding dose. Children with personal or family history of convulsions or epilepsy. Children with a local or general reaction to a whole-cell pertussis vaccine should complete their immunisation with acellular pertussis vaccine. If a seizure associated with fever occurs within 72 hr of immunisation or a child experiences encephalopathy or encephalitis within 7 days of immunisation, defer further immunisation until the condition is stable if no underlying cause is found and the child has not recovered completely within 24 hr. |
Adverse Reactions |
Local reactions at inj site, fever and irritability, may start a few hrs after inj and last for 1 or 2 days, possibly with inflammation and lymphangitis. Rare neurological reactions e.g. convulsions and encephalopathy. Hypersensitivity reactions may occur and anaphylaxis has been reported rarely. |
Drug Interactions |
Reduced immune response in patients who are also taking immunosuppressants. See Below for More vaccine, pertussis Drug Interactions |
Mechanism of Actions |
Pertussis vaccine is used for active immunisation against pertussis. |
Storage Conditions |
Intramuscular: Store at 2-8 °C, do not freeze and protect from light. |
Storage |
Intramuscular: Store at 2-8 °C, do not freeze and protect from light. |
Available As |
|
Pertussis Vaccine
Post Review about Pertussis Vaccine Click here to cancel reply.
Pertussis Vaccine Containing Brands
Pertussis Vaccine is used in following diseases
Drug - Drug Interactions of Pertussis Vaccine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.